Guided Therapeutics (GTHP) Treasury Shares (2010 - 2025)

Guided Therapeutics has disclosed Treasury Shares across 16 years of filings, most recently posting $132000.0 for Q3 2025.

• Treasury Shares for Q3 2025 came in at $132000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $132000.0 (changed 0.0% YoY), and the FY2024 annual result was $132000.0, changed 0.0% from the prior year.
• Treasury Shares came in at $132000.0 for Q3 2025 at Guided Therapeutics, roughly flat from $132000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $678000.0 in Q2 2021 to a low of $300000.0 in Q4 2025.
• The 5-year median for Treasury Shares is $678000.0 (2021), against an average of $652800.0.
• Peak annual rise in Treasury Shares reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
• Guided Therapeutics' Treasury Shares stood at $132000.0 in 2021, then changed by 0.0% to $132000.0 in 2022, then changed by 0.0% to $132000.0 in 2023, then changed by 0.0% to $132000.0 in 2024, then changed by 0.0% to $132000.0 in 2025.
• The last three Treasury Shares figures came in at $132000.0 (Q3 2025), $132000.0 (Q2 2025), and $132000.0 (Q1 2025), per Business Quant data.